Issues related to the development of biologic therapies before Congress, the Food and Drug Administration (FDA), and other federal health agencies.
2025 · 3rd Quarter (July 1 - Sep 30)
ALPHYN BIOLOGICS
Filed by SQUIRE PATTON BOGGS.
Open official filingSource-reported fields
Filing overview
- Type
- Registration
- Posted
- Oct 16, 2025
- Income
- Not reported
- Expenses
- Not reported
- Registrant
- SQUIRE PATTON BOGGS
- Client
- ALPHYN BIOLOGICS
- Filing UUID
- a3fc1668-7edc-430f-8517-22244698b9ae
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to the development of biologic therapies before Congress, the Food and Drug Administration (FDA), and other federal health agencies.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.